SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target

Breast cancer is one of the most common types of cancer in females worldwide, and metastasis to bone is an important characteristic of malignancy. The present study aimed to investigate the molecular mechanism of breast cancer to bone metastasis of secreted protein acidic and rich in cysteine (SPARC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jingjing, Gao, Sheng, Xie, Xiju, Sun, Erhu, Zhang, Min, Zhou, Qian, Lu, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661402/
https://www.ncbi.nlm.nih.gov/pubmed/29113221
http://dx.doi.org/10.3892/ol.2017.6925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661402/
https://www.ncbi.nlm.nih.gov/pubmed/29113221
http://dx.doi.org/10.3892/ol.2017.6925

Ejemplares similares